[Advance and current status of exemestane and androstadienes in the treatment of breast cancer].
Wang
Li-ping
LP
Shen
Kun-wei
KW
Shan
Zhen-zhou
ZZ
D000077384:Anastrozole; D000730:Androstadienes / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D047072:Aromatase Inhibitors / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009570:Nitriles / Q000008:administration & dosage; D017698:Postmenopause; D014230:Triazoles / Q000008:administration & dosage
D000730:Androstadienes; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole; C056516:exemestane